CASP9 and hepatocellular carcinoma: In relation to this anticancer activity, β-thujaplicin has been shown to induce apoptosis in human colon cancer cells through the activation of caspases-9 and -3 [9] and in human hepatocellular carcinoma cells through a mitochondria-dependent intrinsic pathway [13].